91
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients

, , , , , & ORCID Icon show all
Pages 937-941 | Published online: 18 Nov 2021

References

  • Adolfsson J. Health-related quality-of-life assessments in patients with advanced cancer of the prostate. Pharmacoeconomics. 2003;21(4):241–247. doi:10.2165/00019053-200321040-00002
  • Van Leeuwen M, Husson O, Alberti P, et al. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes. 2018;16(1):1–15. doi:10.1186/s12955-018-0920-0
  • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI. 1993;85(5):365–376. doi:10.1093/jnci/85.5.365
  • Heinzer H, Steuber T. Prostate cancer in the elderly. Urol Oncol. 2009;27(6):668–672. Elsevier. doi:10.1016/j.urolonc.2009.07.015
  • Zhou CK, Check DP, Lortet‐Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138(6):1388–1400. doi:10.1002/ijc.29894
  • Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 2020;126(1):46–57. doi:10.1002/cncr.32498
  • Dimitropoulou P, Lophatananon A, Easton D, et al. Sexual activity and prostate cancer risk in men diagnosed at a younger age. BJU Int. 2009;103(2):178–185. doi:10.1111/j.1464-410X.2008.08030.x
  • Rossetti SR, Terrone C. Quality of life in prostate cancer patients. Eur Urol. 1996;30:44–48. doi:10.1159/000474246
  • Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe N. Pandemics: risks, impacts, and mitigation; 2017.
  • Sharma DC. Lockdown poses new challenges for cancer care in India. Lancet Oncol. 2020;21(7):884. doi:10.1016/S1470-2045(20)30312-0
  • Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: a perspective. J Glob Health. 2020;10(1):1. doi:10.7189/jogh.10.010367
  • Hinz A, Weis J, Faller H, et al. Quality of life in cancer patients—a comparison of inpatient, outpatient, and rehabilitation settings. Support Care Cancer. 2018;26(10):3533–3541. doi:10.1007/s00520-018-4211-4
  • Hartman HE, Sun Y, Devasia TP, et al. Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic. JAMA Oncol. 2020;6(12):1881–1889. doi:10.1001/jamaoncol.2020.5403
  • Das S, Patro KC. Cancer care in the rural areas of India: a firsthand experience of a clinical oncologist and review of literatures. J Cancer Res Ther. 2010;6(3):299. doi:10.4103/0973-1482.73369
  • Banavali SD. Delivery of cancer care in rural India: experiences of establishing a rural comprehensive cancer care facility. Indian J Med Paediatr Oncol. 2015;36(2):128. doi:10.4103/0971-5851.158848
  • Basch E. The rise of patient-reported outcomes in oncology. ASCO Daily News; 2016.
  • Campbell N, Ali F, Finlay AY, Salek SS. Equivalence of electronic and paper-based patient-reported outcome measures. Qual Life Res. 2015;24(8):1949–1961. doi:10.1007/s11136-015-0937-3
  • Muehlhausen W, Doll H, Quadri N, et al. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes. 2015;13(1):1–20. doi:10.1186/s12955-015-0362-x
  • Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008;11(2):322–333. doi:10.1111/j.1524-4733.2007.00231.x
  • Cella D, Hahn EA, Jensen SE, Butt Z, Nowinski CJ, Rothrock N. Methodological issues in the selection, administration and use of patient-reported outcomes in performance measurement in health care settings. In: Patient Reported Outcomes (Pros) in Performance Measurement. National Quality Forum (NQF); 2013.
  • Fairclough DL. Practical considerations in outcomes assessment for clinical trials. In: Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, UK: Cambridge University Press; 2005:346–361.
  • Simes RJ, Greatorex V, Gebski VJ. Practical approaches to minimize problems with missing quality of life data. Stat Med. 1998;17(5‐7):725–737. doi:10.1002/(SICI)1097-0258(19980315/15)17:5/7<725::AID-SIM817>3.0.CO;2-1
  • Basch E, Artz D, Dulko D, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005;23(15):3552–3561. doi:10.1200/JCO.2005.04.275
  • Holzner B, Giesinger JM, Pinggera J, et al. The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring. BMC Med Inform Decis Mak. 2012;12(1):1–11. doi:10.1186/1472-6947-12-126